Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fellermann

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|February 28, 2002
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remissionK R Herrlinger, M K Noftz, K Dalhoff, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 20, 2001
[Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus]K Fellermann, B Rudolph, T Witthöft, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Remission maintenance by tioguanine in chronic active Crohn's diseaseK R Herrlinger, P Deibert, M Schwab, et al.
Gut|September 16, 1999
Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up studyD Ludwig, S Wiener, A Brüning, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2000
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel diseaseK Fellermann, M Steffen, J Stein, et al.
Zeitschrift Fur Gastroenterologie|May 15, 2012
[CEUS as a tool to uncover an unusual cause of obstructive jaundice]F Bär, C Sina, K J Schmidt, et al.
Alimentary Pharmacology & Therapeutics|March 24, 2009
Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's diseaseK J Schmidt, K Fellermann, P Wellhöner, et al.
Digestive Diseases and Sciences|September 18, 1999
Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseasesD Ludwig, M Stahl, E T Ibrahim, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitisK R Herrlinger, H Koc, S Winter, et al.
Mucosal Immunology|January 9, 2009
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humansM Möndel, B O Schroeder, K Zimmermann, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|February 28, 2002
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remissionK R Herrlinger, M K Noftz, K Dalhoff, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 20, 2001
[Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus]K Fellermann, B Rudolph, T Witthöft, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Remission maintenance by tioguanine in chronic active Crohn's diseaseK R Herrlinger, P Deibert, M Schwab, et al.
Gut|September 16, 1999
Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up studyD Ludwig, S Wiener, A Brüning, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2000
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel diseaseK Fellermann, M Steffen, J Stein, et al.
Zeitschrift Fur Gastroenterologie|May 15, 2012
[CEUS as a tool to uncover an unusual cause of obstructive jaundice]F Bär, C Sina, K J Schmidt, et al.
Alimentary Pharmacology & Therapeutics|March 24, 2009
Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's diseaseK J Schmidt, K Fellermann, P Wellhöner, et al.
Digestive Diseases and Sciences|September 18, 1999
Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseasesD Ludwig, M Stahl, E T Ibrahim, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitisK R Herrlinger, H Koc, S Winter, et al.
Mucosal Immunology|January 9, 2009
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humansM Möndel, B O Schroeder, K Zimmermann, et al.
Pageof 5